Company Filing History:
Years Active: 2008
Title: Gilberto Fisone: Innovator in Psychopharmacology
Introduction
Gilberto Fisone is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of psychopharmacology, particularly in the classification of anti-psychotic drugs. His work aims to improve the treatment options available for patients suffering from psychotic disorders.
Latest Patents
Gilberto Fisone holds a patent for a method that identifies agents to be tested for their ability to treat psychotic disorders. The patent describes a screening method for candidate drugs that focuses on atypical anti-psychotic activity. This involves contacting cells or tissues with a candidate drug and determining the levels of phosphorylation of specific intracellular signaling proteins, including DARPP-32, ERK1, ERK2, and CREB. The patterns of these phosphorylation levels are then compared to those observed in the presence of known atypical anti-psychotic drugs.
Career Highlights
Fisone's career is marked by his dedication to advancing the understanding of psychotic disorders and the development of effective treatments. His innovative approach to drug screening has the potential to streamline the process of identifying effective anti-psychotic medications.
Collaborations
Gilberto Fisone collaborates with esteemed colleagues, including Paul Greengard, who is also recognized for his contributions to neuroscience and pharmacology. Their partnership exemplifies the collaborative spirit of research in the scientific community.
Conclusion
Gilberto Fisone's work in the classification of anti-psychotic drugs represents a significant advancement in the field of psychopharmacology. His innovative methods have the potential to enhance treatment options for patients in need.